secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2022-07-18T23:59:59+00:00
Accession:  0001493152-22-019579
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Enveric Biosciences appoints Frank Pasqualone to Board, effective July 13, 2022
-------------------------------------------------------------------------------

- Frank Pasqualone appointed to board, filling vacancy from size increase from 8 to 9 directors.
- Term expires at 2022 annual meeting; successor to be elected or until earlier resignation.
- No arrangements with any person or reportable transactions under Item 404(a).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315222019579/0001493152-22-019579-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315222019579/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-019579

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer